GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.550
+0.080 (5.44%)
At close: May 12, 2025, 4:00 PM
1.540
-0.010 (-0.65%)
After-hours: May 12, 2025, 7:52 PM EDT
GRI Bio Stock Forecast
GRI's stock price has decreased by -98.29% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 2 analysts with 12-month price forecasts for GRI Bio stock have an average target of 115.5, with a low estimate of 10 and a high estimate of 221. The average target predicts an increase of 7,351.61% from the current stock price of 1.55.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for GRI Bio stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +545.16% | Apr 14, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $170 | Strong Buy | Initiates | $170 | +10,867.74% | Dec 9, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $204 → $221 | Strong Buy | Maintains | $204 → $221 | +14,158.06% | Dec 5, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $204 | Strong Buy | Initiates | $204 | +13,061.29% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-15.88
from -55.21
EPS Next Year
-11.68
from -15.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | n/a | n/a | n/a | |
| Avg | n/a | n/a | n/a | |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -16.07 | -12.14 | -6.78 | |
| Avg | -15.88 | -11.68 | -6.52 | |
| Low | -15.83 | -11.33 | -6.33 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.